Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-12 · accession 0001601830-24-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-14 | 2024-03-12+ | RXRX | Secora Michael | CFO | S - Sale+OE | $10.74 | -50.0K | 1.19M | -4% | -$537.2K |
| DM | 2024-03-14 | 2024-03-12+ | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.22M | +7% | +$166.5K |
| DM | 2024-03-14 | 2024-03-12+ | RXRX | Secora Michael | CFO | M - OptEx | $0.00 | -75.0K | 922.6K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-13 | S | D | 25,000 | $11.03 | 1,204,179 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $10.98 to $11.33 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2024-03-13 | M | A | 37,500 | $2.22 | 1,229,179 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-03-12 | S | D | 25,000 | $10.46 | 1,191,679 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $10.21 to $10.67 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2024-03-12 | M | A | 37,500 | $2.22 | 1,216,679 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-03-13 | M | D | 37,500 | $0.00 | 885,135 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F4) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-03-12 | M | D | 37,500 | $0.00 | 922,635 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F4) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |